Specifically, the risk variants in PNPLA3, TM6SF2, MBOAT7, GCKR and the protective variant in HSD17B13 genes are mostly related to the lipid handling in the hepatocytes and are associated with MASLD onset and progression [10,11,12]. This evidence concerns the gene HSD17B13 and metabolic dysfunction-associated steatotic liver disease.